Ftse Mib
36.719,35
0,00%
DAX
21.510,84
0,00%
S&P 500
6.037,88
0,72%
NASDAQ
19.654,02
1,35%
Bitcoin
97.973,83
0,12%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ ATAI Life Sciences NV (ATAI) ATAI Life Sciences NV (ATAI) Notizie

ATAI Life Sciences NV

ATAI
2,25
0,00 (0,00%)
05 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
28/1/202513:00GLOBEatai Life Sciences Announces Positive Topline Results from..
24/1/202522:15EDGAR2Form 8-K - Current report
10/1/202522:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202522:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/1/202522:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/1/202513:23EDGAR2Form 8-K - Current report
10/1/202513:00GLOBEatai Life Sciences Announces Key Leadership Appointments as..
13/12/202422:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/11/202414:19EDGAR2Form 8-K - Current report
13/11/202414:00GLOBEatai Life Sciences Reports Third Quarter 2024 Financial..
11/11/202413:30GLOBEAltimmune Appoints Life Sciences Industry Veteran Greg..
15/10/202414:00GLOBEatai Life Sciences to Participate in the 2024 Maxim..
04/10/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202422:02EDGAR2Form 8-K - Current report
04/9/202413:00GLOBEatai Life Sciences to Participate in the H.C. Wainwright..
14/8/202413:00EDGAR2Form 8-K - Current report
13/8/202413:23EDGAR2Form 8-K - Current report
13/8/202413:10GLOBEatai Life Sciences Reports Second Quarter 2024 Financial..
13/8/202413:00GLOBEatai Life Sciences Announces Positive Preliminary Results..
07/8/202413:00GLOBEatai Life Sciences to Participate in the Canaccord Genuity..
26/6/202413:00GLOBEatai Life Sciences to Participate in the H.C. Wainwright 5th..
20/6/202413:00GLOBEatai Life Sciences Announces Update on Beckley Psytech’s..
14/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202414:00EDGAR2Form 8-K - Current report
31/5/202413:00GLOBEatai Life Sciences to Participate in the Jefferies 2024..
23/5/202413:10EDGAR2Form 8-K - Current report
23/5/202413:00GLOBEatai Life Sciences Strengthens Board with Appointment of Two..
20/5/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202413:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/5/202413:15EDGAR2Form 8-K - Current report
15/5/202412:59GLOBEatai Life Sciences Reports First Quarter 2024 Financial..
24/4/202413:00GLOBEatai Life Sciences Announces Dosing of First Patient in Part..
17/4/202413:00GLOBEatai Life Sciences Announces the Publication of Beckley..
28/3/202412:00GLOBEatai Life Sciences Reports Fourth Quarter and Full Year 2023..
27/3/202412:00GLOBEatai Life Sciences Announces Positive Initial Results from..
04/3/202414:00GLOBEatai Life Sciences Announces First Participant Dosed in..
28/2/202423:00GLOBEatai Life Sciences to Participate in the Upcoming TD Cowen..
13/2/202422:29EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202423:05EDGAR2Form 8-K - Current report
06/2/202423:00GLOBEatai Life Sciences Appoints Anne Johnson as Chief Financial..
Apertura: Min: Max:
Chiusura: 2,25

La tua Cronologia

NASDAQ
ATAI
ATAI Life Sciences NV
USOTC
KNBIF
Kane Biotech (QB)
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci